A Comparative Clinical and Cost-effectiveness Evaluation of Gefitinib and Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
Invited conference paper presented and published in conference proceedings

Full Text

Other information
All Author(s) ListLOPES Dl Gilberto, SEGEL Joel, TAN Daniel, DO Young, MOK Shu Kam Tony, FINKELSTEIN Eric
Name of ConferenceProceedings of the 14th World Conference on Lung Cancer
Country/Region of ConferenceUnited States of America
Proceedings TitleProceedings of the 14th World Conference on Lung Cancer
Detailed descriptionorganized by IASLC,
Place of PublicationUnited States of America
LanguagesEnglish-United Kingdom
KeywordsGefitinib; Erlotinib; NSCLC

Last updated on 2021-07-05 at 11:07